Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 11 | Infectious Agents and Cancer

Fig. 11

From: Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi’s sarcoma–associated herpesvirus

Fig. 11

Drug screening for cell death and KSHV activation in SPEL cells. a Cell viability at 48 h after the addition of a drug to the culture medium. b Expression ratio of RTA to GAPDH mRNA at 48 h after the addition of a drug to the culture medium by real-time RT-PCR. Detailed information regarding the drugs and concentrations used are listed in Table 1

Back to article page